Authors
Latest:
Consider New Treatment Options for COPDPharmacists should familiarize themselves with these therapies to help patients lessen the risk of emergency department visits and hospitalizations.
Latest:
Lung Cancers: Facts, Causes, and TypesIn 2017, lung cancer is projected to be the second most prevalent type of cancer in the United States, with about 222,500 new cases and is estimated to still be the leading cause of cancer-related death, with 155,870 deaths.
Latest:
Emerging Trends in Adherence and Quality Measurement: What the Future HoldsAdherence measurement can help patients achieve better outcomes.
Latest:
The Comparative Value of 3 Electronic Sources of Medication DataCombining medication history information from multiple sources improves the completeness and accuracy of the medication information.
Latest:
Improve Medication Adherence in Patients with HIVPharmacists can motivate patients to stick to their drug regimens to decrease viral load and prevent further transmission.
Latest:
Medication Formulary Management in a Large, Multihospital SystemClarian Health, an 11-hospital health system, developed and managed a multihospital formulary through focused planning and collaboration.
Latest:
Short-Term and Long-Term Impact of COVID-19 on Community PharmacyWhether it be delivery options, remote pharmacy, increasing roles for pharmacists and technicians, or fluctuating patient volume, the impact of COVID-19 can be felt in community pharmacies across the United States.
Latest:
Hybrid Models Can Transform Team ChemistryMorristown Medical Center’s area-based pharmacist program leads to an increase in direct patient contact and opportunities for interventions.
Latest:
Combination Shows Promise for Treating Advanced Non Small Cell Lung CancerCombining pegilodecakin (AM0010) with nivolumab (Opdivo) or pembrolizumab (Keytruda) induced an overall response rate (ORR) of 41% in patients with advanced non–small cell lung cancer (NSCLC), according to findings from an early phase study presented at the 2018 ASCO Annual meeting.
Latest:
A Population-Based Approach to Improving Patient Safety Related to Drug—Drug InteractionsSome medication combinations are a source of preventable drug-related harm. A multifaceted approach is needed to address this quality-of-care issue.
Latest:
Determinants of Primary Nonadherence in Asthma-Controller and Dyslipidemia PharmacotherapyThis study linked e-prescribing records to paid pharmacy claims to identify primary nonadherence rates and factors associated with unfilled prescriptions.
Latest:
Defining the Teriparatide Patient: Osteoporosis Sequence of Care and Healthcare ResourcesThis study provides real-world evidence of a teriparatide (TPTD) patient’s characteristics, sequence of care, and healthcare resource utilization, and compares TPTD patients with non-TPTD patients.
Latest:
Apixaban: A New Treatment Option for Cancer-Associated VTEOptimizing the best pharmaceutical agent while minimizing adverse effects is paramount in patients with cancer-associated venous thromboembolism.
Latest:
NASP Meeting Shines Light on Challenges, Opportunities in Specialty PharmacyNASP maintains a strong focus on policies affecting the national, legislative, and regulatory landscape of specialty pharmacy year round.
Latest:
Utilization Impacts of New Oral Substitutes for Parenteral Cancer-Related TherapiesExamination of changes in utilization, dose adequacy, and duration associated with market entry of the oral chelator deferasirox as a potential substitute for parenteral deferoxamine.
Latest:
Value-Based Contracts and Health Systems Specialty Pharmacy Integration: 2 Key Insights From Asembia 2017The summit provides a place for specialty pharmacy stakeholders to discuss the industry.
Latest:
Rapid Deployment of Prior Authorization PoliciesIn an effort to minimize the cost curve, payers have been adjusting their utilization management policies, spurred by the approval of several costly new hepatitis C medications.
Latest:
How to Manage the Symptoms of Autoimmune DiseaseAutoimmune diseases are often chronic conditions that can evolve, so minimizing damage and progression is typically the mainstay of treatment.
Latest:
Chaotic Health Care Landscape Breeds Opportunity for PharmacistsIn the current chaotic environment of reimbursement that depends on quality and cost savings, pharmacists should increase their presence.
Latest:
Delivering on the Potential of the Specialty Pipeline: 3 Disruptive Trends in Specialty PharmacyPharmacy stakeholders must be nimble and responsive to innovations and disruptive trends in the market.
Latest:
Rare Pharmacy Emerges From Specialty, Part 3The series concludes looking at the proposition that patients with rare and devastating disorders require and deserve a higher acuity of care and service that only an accredited rare pharmacy can deliver.
Latest:
New ACT Program Brings Challenges and BarriersBoise VA Medical Center in Idaho develops an accuracy checking technician service and shares lessons from the implementation.
Latest:
Budget Impact of Everolimus in Treating Metastatic Renal Cell CarcinomaA decision-analytical model shows that everolimus has a favorable budget impact when introduced into the treatment algorithm for metastatic renal cell carcinoma.
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
